[Edaily JAEMIN SONG Choi Oh-hyun Reporter] “We are executing investments to expand production capacity in response to robust customer demand and medium- to long-term growth opportunities. With accelerated timelines and expanded investment, we expect this year’s investment volume to reach the high 40 trillion won range. In the short term, to enhance our supply responsiveness, we are accelerating the mass production schedule for M15X and investing to ensure we can rapidly expand production capacity following the opening of the cleanroom at the first phase of the Yongin fab in early 2027. We also plan to establish the advanced packaging plant P&T7, the new NAND production base M17, and a new domestic semiconductor cluster to meet long-term demand over the medium to long term. “We will proceed in stages with actual fab construction, equipment deployment, and production capacity expansion, taking into comprehensive consideration factors such as the visibility of customer demand and investment efficiency. We will strengthen both our supply responsiveness and financial soundness while adhering to our capital expenditure principles.”
…SK hynix Q2 2026 Conference Call
A view of SK hynix’s headquarters in Icheon, Gyeonggi Province. (Photo: Yonhap News)
(Photo: Blind)
One of the concerns facing the Lee Jae-myung administration is the decline in support among young people. According to Gallup Korea’s presidential job approval ratings, the approval…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
(Graphic: ChatGPT)
“While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…